| 1 301 | Crinetics Pharmaceuticals Inc | 30 576 | 1,1 M $ | |
| 1 302 | Cogent Biosciences Inc | 28 646 | 1,1 M $ | |
| 1 303 | Arcellx Inc | 9 477 | 1,1 M $ | |
| 1 304 | Scholar Rock Holding Corp | 21 354 | 1 M $ | |
| 1 305 | Apellis Pharmaceuticals Inc | 25 896 | 1 M $ | |
| 1 306 | Terns Pharmaceuticals Inc | 19 440 | 1 M $ | |
| 1 307 | Supernus Pharmaceuticals Inc | 19 596 | 1 M $ | |
| 1 308 | CG oncology Inc | 14 617 | 989,3 k $ | |
| 1 309 | Catalyst Pharmaceuticals Inc | 39 737 | 983,9 k $ | |
| 1 310 | Twist Bioscience Corp | 20 629 | 980,3 k $ | |
| 1 311 | Eos Energy Enterprises Inc | 196 413 | 974,2 k $ | |
| 1 312 | Prestige Consumer Healthcare Inc | 16 433 | 974 k $ | |
| 1 313 | Erasca Inc | 58 176 | 941,3 k $ | |
| 1 314 | Apogee Therapeutics Inc | 11 073 | 932 k $ | |
| 1 315 | Denali Therapeutics Inc | 47 471 | 911,4 k $ | |
| 1 316 | ImmunityBio Inc | 117 817 | 903,7 k $ | |
| 1 317 | ACADIA Pharmaceuticals Inc | 40 473 | 900,9 k $ | |
| 1 318 | Ideaya Biosciences Inc | 26 958 | 898,2 k $ | |
| 1 319 | Arcutis Biotherapeutics Inc | 37 676 | 887,6 k $ | |
| 1 320 | Veracyte Inc | 27 016 | 870,2 k $ | |
| 1 321 | Travere Therapeutics Inc | 29 049 | 863 k $ | |
| 1 322 | Spyre Therapeutics Inc | 16 720 | 843,4 k $ | |
| 1 323 | Immunocore Holdings PLC | 27 663 | 834 k $ | |
| 1 324 | Celcuity Inc | 7 116 | 812,2 k $ | |
| 1 325 | Liquidia Corp | 20 812 | 785,4 k $ | |
| 1 326 | Tarsus Pharmaceuticals Inc | 10 880 | 763,2 k $ | |
| 1 327 | Beam Therapeutics Inc | 31 212 | 743,8 k $ | |
| 1 328 | Sarepta Therapeutics Inc | 34 021 | 740,3 k $ | |
| 1 329 | ADMA Biologics Inc | 81 337 | 732,8 k $ | |
| 1 330 | Dyne Therapeutics Inc | 39 390 | 714,1 k $ | |
| 1 331 | Immunome Inc | 32 052 | 701 k $ | |
| 1 332 | Immunovant Inc | 27 542 | 684,1 k $ | |
| 1 333 | BioCryst Pharmaceuticals Inc | 70 830 | 674,3 k $ | |
| 1 334 | Amneal Pharmaceuticals Inc | 53 718 | 667,7 k $ | |
| 1 335 | Syndax Pharmaceuticals Inc | 27 968 | 653,3 k $ | |
| 1 336 | Celldex Therapeutics Inc | 20 439 | 648,3 k $ | |
| 1 337 | Arcus Biosciences Inc | 29 600 | 639,4 k $ | |
| 1 338 | Sila Realty Trust Inc | 27 000 | 639,4 k $ | |
| 1 339 | Agios Pharmaceuticals Inc | 18 864 | 638,2 k $ | |
| 1 340 | Ultragenyx Pharmaceutical Inc | 29 675 | 621,7 k $ | |
| 1 341 | GRAIL Inc | 11 990 | 619,6 k $ | |
| 1 342 | Clipper Realty Inc | 204 993 | 619,1 k $ | |
| 1 343 | Nektar Therapeutics | 8 288 | 596,3 k $ | |
| 1 344 | Park Hotels & Resorts Inc | 55 000 | 579,2 k $ | |
| 1 345 | Edgewise Therapeutics Inc | 18 091 | 569,9 k $ | |
| 1 346 | Innoviva Inc | 24 275 | 565,6 k $ | |
| 1 347 | Apartment Investment and Management Co | 138 773 | 564,8 k $ | |
| 1 348 | Vericel Corp | 17 284 | 556 k $ | |
| 1 349 | Organon & Co | 88 851 | 532,2 k $ | |
| 1 350 | Disc Medicine Inc | 8 317 | 531,8 k $ | |
| 1 351 | Day One Biopharmaceuticals Inc | 24 563 | 526,6 k $ | |
| 1 352 | Vera Therapeutics Inc | 13 087 | 526,5 k $ | |
| 1 353 | Soleno Therapeutics Inc | 15 602 | 522,4 k $ | |
| 1 354 | Capricor Therapeutics Inc | 16 733 | 508,7 k $ | |
| 1 355 | Ardelyx Inc | 83 038 | 497,4 k $ | |
| 1 356 | Alumis Inc | 22 087 | 486,6 k $ | |
| 1 357 | Intellia Therapeutics Inc | 37 606 | 482,1 k $ | |
| 1 358 | ANI Pharmaceuticals Inc | 6 140 | 472,2 k $ | |
| 1 359 | Medical Properties Trust Inc | 100 999 | 467,6 k $ | |
| 1 360 | Recursion Pharmaceuticals Inc | 151 428 | 464,9 k $ | |
| 1 361 | Ocular Therapeutix Inc | 54 608 | 462,5 k $ | |
| 1 362 | Dianthus Therapeutics Inc | 5 443 | 456,8 k $ | |
| 1 363 | Stoke Therapeutics Inc | 13 664 | 444,9 k $ | |
| 1 364 | Xenia Hotels & Resorts Inc | 30 000 | 444,9 k $ | |
| 1 365 | Enliven Therapeutics Inc | 11 155 | 437,3 k $ | |
| 1 366 | Viridian Therapeutics Inc | 22 269 | 435,6 k $ | |
| 1 367 | Mineralys Therapeutics Inc | 15 604 | 422,7 k $ | |
| 1 368 | Harmony Biosciences Holdings Inc | 14 747 | 413,1 k $ | |
| 1 369 | Relay Therapeutics Inc | 41 464 | 412,6 k $ | |
| 1 370 | Nurix Therapeutics Inc | 25 983 | 402,7 k $ | |
| 1 371 | Phibro Animal Health Corp | 6 988 | 386,5 k $ | |
| 1 372 | Novavax Inc | 47 205 | 384,2 k $ | |
| 1 373 | Harrow Inc | 10 759 | 379,4 k $ | |
| 1 374 | Kodiak Sciences Inc | 9 929 | 378,5 k $ | |
| 1 375 | Iovance Biotherapeutics Inc | 105 116 | 369 k $ | |
| 1 376 | Endava PLC | 82 819 | 366,1 k $ | |
| 1 377 | Oruka Therapeutics Inc | 7 441 | 365 k $ | |
| 1 378 | Collegium Pharmaceutical Inc | 10 803 | 357,3 k $ | |
| 1 379 | Braemar Hotels & Resorts Inc | 147 995 | 349,3 k $ | |
| 1 380 | Trevi Therapeutics Inc | 29 133 | 347,6 k $ | |
| 1 381 | Seaport Entertainment Group Inc | 15 891 | 341,3 k $ | |
| 1 382 | Xeris Biopharma Holdings Inc | 56 706 | 328,9 k $ | |
| 1 383 | EyePoint Inc | 25 464 | 328,2 k $ | |
| 1 384 | Palvella Therapeutics Inc | 2 629 | 327,7 k $ | |
| 1 385 | Nuvation Bio Inc | 75 811 | 325,2 k $ | |
| 1 386 | Zymeworks Inc | 12 788 | 320,2 k $ | |
| 1 387 | Tango Therapeutics Inc | 15 210 | 318,2 k $ | |
| 1 388 | Pacira BioSciences Inc | 13 968 | 315,7 k $ | |
| 1 389 | Amylyx Pharmaceuticals Inc | 22 519 | 313 k $ | |
| 1 390 | Rapport Therapeutics Inc | 9 773 | 305,8 k $ | |
| 1 391 | CareDx Inc | 17 281 | 300 k $ | |
| 1 392 | Vir Biotechnology Inc | 30 906 | 276,9 k $ | |
| 1 393 | Amarin Corp PLC | 18 879 | 273 k $ | |
| 1 394 | AnaptysBio Inc | 4 784 | 265,3 k $ | |
| 1 395 | Tilray Brands Inc | 39 817 | 257,6 k $ | |
| 1 396 | Amphastar Pharmaceuticals Inc | 12 564 | 246,1 k $ | |
| 1 397 | MannKind Corp | 99 618 | 244,1 k $ | |
| 1 398 | Geron Corp | 163 622 | 243,8 k $ | |
| 1 399 | Precigen Inc | 60 502 | 234,1 k $ | |
| 1 400 | MBX Biosciences Inc | 7 673 | 229 k $ | |